Latest On Convatec Group Plc (CNVVF):
About Convatec Group Plc (CNVVF):
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group Plc was incorporated in 2016 and is headquartered in Reading, the United Kingdom.
General
- Name Convatec Group Plc
- Symbol CNVVF
- Type Common Stock
- Exchange OTCGREY
- Currency USD
- Country USA
- Full Time Employees 9,600
- Fiscal Year EndDecember
- Web URLhttp://www.convatecgroup.com
Valuation
- Trailing PE 47.58
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 6%
- Operating Margin 12%
- Return on Assets 4%
- Return on Equity 7%
- Revenue 1.89 billion
- Earnings Per Share $0.06
- Revenue Per Share $0.95
- Gross Profit 1.02 billion
- Quarterly Earnings Growth 5.1%
Highlights
- Market Capitalization 5.4 billion
- EBITDA 390.8 million
- Book Value Per Share $0.84
Share Statistics
- Shares Outstanding 1.95 billion
- Shares Float 1.57 billion
- % Held by Insiders 2028%
- % Held by Institutions 63.74%
Technicals
- Beta 0.73
- 52 Week High $2.78
- 52 Week Low $2.36
- 50 Day Moving Average 2.74
- 200 Day Moving Average 2.57
Dividends
- Dividend Date 2017-10-20
- ExDividend Date N/A
- Dividend Per Share $0.06
- Dividend Yield 0%
Convatec Group Plc (CNVVF) Dividend Calendar:
CNVVF's last dividend payment was made to shareholders on October 20, 2017.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Convatec Group Plc (CNVVF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-12-31 | $N/A | $0.01 | $0.00 | |
2020-06-30 | 2020-09-30 | $N/A | $0.01 | $0.00 | |
2020-03-31 | 2020-06-30 | $N/A | $0.01 | $0.00 | |
2019-12-31 | 2020-03-31 | $469.15 million | $0.01 | $0.00 | |
2019-09-30 | 2019-12-31 | $469.15 million | -$0.01 | $0.00 | |
2019-06-30 | 2019-09-30 | $444.45 million | -$0.01 | $0.00 | |
2019-03-31 | 2019-06-30 | $444.45 million | $0.01 | $0.00 | |
2018-12-31 | 2019-03-31 | $455.4 million | $0.01 | $0.00 | |
2018-09-30 | 2018-12-31 | $455.4 million | $0.03 | $0.00 | |
2018-06-30 | 2018-09-30 | $536.14 million | $0.03 | $0.00 | |
2018-03-31 | 2018-06-30 | $566.67 million | $0.03 | $0.00 | |
2017-12-31 | 2018-03-31 | $466.65 million | $0.03 | $0.00 | |
2017-09-30 | 2017-12-31 | $466.65 million | $0.03 | $0.00 | |
2017-06-30 | 2017-09-30 | $415.65 million | $0.03 | $0.00 | |
2017-03-31 | 2017-06-30 | $415.65 million | $0.01 | $0.00 | |
2016-12-31 | 2017-03-31 | $429.7 million | $0.01 | $0.00 | |
2016-09-30 | 2016-12-31 | $429.7 million | -$0.04 | $0.00 | |
2016-06-30 | 2016-09-30 | -$0.04 | $0.00 | ||
2016-03-31 | 2016-06-30 | -$0.32 | $0.00 | ||
2015-12-31 | 2016-03-31 | -$0.36 | $0.00 | ||
2015-09-30 | 2015-12-31 | $0.81 | $0.00 | ||
2015-06-30 | 2015-09-30 | -$0.30 | $0.00 | ||
2015-03-31 | 2015-06-30 | -$0.69 | $0.00 | ||
2014-12-31 | 2015-03-31 | -$0.66 | $0.00 | ||
2014-09-30 | 2014-12-31 | -$1.25 | $0.00 | ||
2014-06-30 | 2014-09-30 | -$0.21 | $0.00 | ||
2014-03-31 | 2014-06-30 | -$0.47 | $0.00 | ||
2013-12-31 | 2014-03-31 | -$0.63 | $0.00 | ||
2013-09-30 | 2013-12-31 | -$0.58 | $0.00 | ||
2013-06-30 | 2013-09-30 | -$0.22 | $0.00 | ||
2013-03-31 | 2013-06-30 | -$0.33 | $0.00 | ||
2012-12-31 | 2013-03-31 | -$0.43 | $0.00 | ||
2012-09-30 | 2012-12-31 | $0.14 | $0.00 | ||
2012-06-30 | 2012-09-30 | -$0.45 | $0.00 | ||
2012-03-31 | 2012-06-30 | -$0.43 | $0.00 | ||
2011-12-31 | 2012-03-31 | -$0.69 | $0.00 | ||
2011-09-30 | 2011-12-31 | -$0.50 | $0.00 | ||
2011-06-30 | 2011-09-30 | $0.25 | $0.00 | ||
2011-03-31 | 2011-06-30 | -$1.19 | $0.00 | ||
2010-12-31 | 2011-03-31 | -$1.10 | $0.00 | ||
2010-09-30 | 2010-12-31 | -$2.70 | $0.00 |
Convatec Group Plc (CNVVF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Research Development | N/A | N/A | N/A | N/A | 15.05 million |
Income Before Tax | N/A | N/A | N/A | N/A | -21.2 million |
Selling General Administrative | N/A | N/A | N/A | N/A | 185.6 million |
Gross Profit | N/A | N/A | N/A | N/A | 248.2 million |
Ebit | N/A | N/A | N/A | N/A | -5.2 million |
Operating Income | N/A | N/A | N/A | N/A | -5.2 million |
Income Tax Expense | 19.9 million | 19.9 million | 11.2 million | 11.2 million | -3.85 million |
Total Revenue | N/A | N/A | N/A | N/A | 469.15 million |
Cost of Revenue | N/A | N/A | N/A | N/A | 220.95 million |
Total Other Income Expense Net | N/A | N/A | N/A | N/A | -16 million |
Net Income From Continuing Operations | N/A | N/A | N/A | N/A | -17.35 million |
Net Income Applicable to Common Shares | 26.7 million | 26.7 million | 29.55 million | 29.55 million | -17.35 million |
Cash Flow:
Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
---|---|---|---|---|---|
Investments | N/A | N/A | N/A | N/A | N/A |
Change to Liabilities | 200000 | 200000 | 21.15 million | 21.15 million | 750000 |
Total Cash Flow from Investing Activities | -18.35 million | -18.35 million | -20.85 million | -20.85 million | -15.55 million |
Net Borrowings | -5.15 million | -5.15 million | -58.6 million | -58.6 million | -20.7 million |
Total Cash Flow from Financial Activities | N/A | N/A | -76 million | -76 million | -50.25 million |
Change to Operating Activities | -150000 | -150000 | -20.7 million | -20.7 million | 21.35 million |
Change in Cash | N/A | N/A | 4.9 million | 4.9 million | 30.2 million |
Total Cash from Operating Activities | 77.55 million | 77.55 million | 103.9 million | 103.9 million | 97 million |
Depreciation | N/A | N/A | 55.45 million | 55.45 million | 49.45 million |
Other Cash Flow from Investing Activities | N/A | N/A | 200000 | 200000 | 200000 |
Change to Inventory | N/A | N/A | 4.7 million | 4.7 million | 5.5 million |
Change to Account Receivables | N/A | N/A | 2.35 million | 2.35 million | -9.3 million |
Other Cash Flow from Financing Activities | N/A | N/A | -10.4 million | -10.4 million | N/A |
Change to Net Income | 9.95 million | 9.95 million | 61.85 million | 61.85 million | 3.45 million |
Capital Expenditures | N/A | N/A | 15.25 million | 15.25 million | 15.45 million |
Balance Sheet:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Total Liabailities | N/A | N/A | N/A | N/A | 2.05 billion |
Total Stockholder Equity | N/A | N/A | N/A | N/A | 1.56 billion |
Other Current Liabilities | 72.7 million | 72.7 million | N/A | N/A | 48.8 million |
Total Assets | N/A | N/A | N/A | N/A | 3.61 billion |
Common Stock | 245.5 million | 245.5 million | 245 million | 245 million | 242.9 million |
Other Current Assets | 6.4 million | 6.4 million | N/A | N/A | N/A |
Retained Earnings | -845.3 million | -845.3 million | -864.4 million | -864.4 million | -847.7 million |
Other Liabilities | 132.8 million | 132.8 million | 145.9 million | 145.9 million | 136.1 million |
Other Assets | 60.4 million | 60.4 million | 72.9 million | 72.9 million | 68.5 million |
Cash | N/A | N/A | N/A | N/A | 385.8 million |
Total Current Liabilities | 513.2 million | 513.2 million | N/A | N/A | 397.3 million |
Other Stockholder Equity | 2.16 billion | 2.16 billion | 2.05 billion | 2.05 billion | 2.11 billion |
Property, Plant & Equipment | 438 million | 438 million | 402.1 million | 402.1 million | 406.1 million |
Total Current Assets | 1.18 billion | 1.18 billion | N/A | N/A | 968.3 million |
Long Term Investments | N/A | N/A | N/A | N/A | N/A |
Net Tangible Assets | -418.9 million | -418.9 million | -538.2 million | -538.2 million | -605.9 million |
Short Term Investments | N/A | N/A | N/A | N/A | N/A |
Long Term Debt | N/A | N/A | N/A | N/A | 1.45 billion |
Inventory | 297.1 million | 297.1 million | N/A | N/A | 281.8 million |
Accounts Payable | 334.1 million | 334.1 million | N/A | N/A | 289.3 million |
Convatec Group Plc (CNVVF) Chart:
Convatec Group Plc (CNVVF) News:
Below you will find a list of latest news for Convatec Group Plc (CNVVF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Convatec Group Plc (CNVVF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Convatec Group Plc (CNVVF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2017-04-19 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000101915517000112/0001019155-17-000112-index.htm |
2017-01-12 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000119380517000033/0001193805-17-000033-index.htm |
2017-03-08 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000119380517000422/0001193805-17-000422-index.htm |
2017-07-25 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000119380517001315/0001193805-17-001315-index.htm |
2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1694271/000119380517002644/0001193805-17-002644-index.htm |
2019-11-25 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1694271/000119380519001848/0001193805-19-001848-index.htm |